BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31598728)

  • 1. Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data.
    van Oosten MJM; Logtenberg SJJ; Leegte MJH; Bilo HJG; Mohnen SM; Hakkaart-van Roijen L; Hemmelder MH; de Wit GA; Jager KJ; Stel VS
    Nephrol Dial Transplant; 2020 Dec; 35(12):2138-2146. PubMed ID: 31598728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
    Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA
    PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
    Zhang H; Zhang C; Zhu S; Ye H; Zhang D
    BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
    Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
    Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting hospital costs for patients receiving renal replacement therapy to inform an economic evaluation.
    Li B; Cairns J; Fotheringham J; Ravanan R;
    Eur J Health Econ; 2016 Jul; 17(6):659-68. PubMed ID: 26153418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study.
    Verberne WR; Dijkers J; Kelder JC; Geers ABM; Jellema WT; Vincent HH; van Delden JJM; Bos WJW
    BMC Nephrol; 2018 Aug; 19(1):205. PubMed ID: 30115028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of patients with chronic kidney disease in Germany.
    Gandjour A; Armsen W; Wehmeyer W; Multmeier J; Tschulena U
    PLoS One; 2020; 15(4):e0231375. PubMed ID: 32330140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review.
    Elshahat S; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
    PLoS One; 2020; 15(3):e0230512. PubMed ID: 32208435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health system in Chile: the nephrologist perspective.
    Ardiles LG; Poblete H; Ortiz M; Elgueta S; Cusumano AM; Vukusich A; Mezzano S
    J Nephrol; 2011; 24(2):149-54. PubMed ID: 21360477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls.
    van Oosten MJM; Logtenberg SJJ; Hemmelder MH; Leegte MJH; Bilo HJG; Jager KJ; Stel VS
    Clin Kidney J; 2021 Dec; 14(12):2497-2523. PubMed ID: 34950462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.
    Vanholder R; Annemans L; Brown E; Gansevoort R; Gout-Zwart JJ; Lameire N; Morton RL; Oberbauer R; Postma MJ; Tonelli M; Biesen WV; Zoccali C;
    Nat Rev Nephrol; 2017 Jul; 13(7):393-409. PubMed ID: 28555652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of chronic kidney disease in Korea using national sample cohort.
    Kim SH; Jo MW; Go DS; Ryu DR; Park J
    J Nephrol; 2017 Dec; 30(6):787-793. PubMed ID: 28303461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Kidney Disease: The Complex History of the Organization of Long-Term Care and Bioethics. Why Now, More Than Ever, Action is Needed.
    Versino E; Piccoli GB
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30836681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Issues of Chronic Kidney Disease and End-Stage Renal Disease.
    Takemoto Y; Naganuma T
    Contrib Nephrol; 2019; 198():87-93. PubMed ID: 30991413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme.
    Jha V; Al-Ghamdi SMG; Li G; Wu MS; Stafylas P; Retat L; Card-Gowers J; Barone S; Cabrera C; Garcia Sanchez JJ
    Adv Ther; 2023 Oct; 40(10):4405-4420. PubMed ID: 37493856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.